Home  |  Contact

UniProtKB/Swiss-Prot P28331: Variant p.Asp252Gly

NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial
Gene: NDUFS1
Chromosomal location: 2q33-q34
Variant information

Variant position:  252
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Aspartate (D) to Glycine (G) at position 252 (D252G, p.Asp252Gly).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and acidic (D) to glycine (G)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Mitochondrial complex I deficiency, nuclear type 5 (MC1DN5) [MIM:618226]: A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN5 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:11349233}. Note=The disease is caused by mutations affecting the gene represented in this entry.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  In MC1DN5.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  252
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  727
The length of the canonical sequence.

Location on the sequence:   TSKPYAFTARPWETRKTESI  D VMDAVGSNIVVSTRTGEVMR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TSKPYAFTARPWETRKTESIDVMDAVGSNIVVSTRTGEVMR

Gorilla                       TSKPYAFTARPWETRKTESIDVMDAVGSNIVVSTRTGEVMR

Chimpanzee                    TSKPYAFTARPWETRKTESIDVMDAVGSNIVVSTRTGEVMR

Mouse                         TSKPYAFTARPWETRKTESIDVMDAVGSNIVVSTRTGEVMR

Rat                           TSKPYAFTARPWETRKTESIDVMDAVGSNIVVSTRTGEVMR

Bovine                        TSKPYAFTARPWETRKTESIDVMDAVGSNIVVSTRTGEVMR

Drosophila                    TNKPYSFVARPWEIRKVSSIDVLDAVGSNIVVSTRTNEVLR

Slime mold                    TSAVYAYKGRPWELKNIKGIDIFDTLLTPINYQVKGGEIFR

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 24 – 727 NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial
Domain 245 – 301 4Fe-4S Mo/W bis-MGD-type


Literature citations

Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency.
Benit P.; Chretien D.; Kadhom N.; de Lonlay-Debeney P.; Cormier-Daire V.; Cabral A.; Peudenier S.; Rustin P.; Munnich A.; Roetig A.;
Am. J. Hum. Genet. 68:1344-1352(2001)
Cited for: INVOLVEMENT IN MC1DN5; VARIANTS MC1DN5 TRP-241 AND GLY-252;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.